PHARMACOKINETIC AND CONCENTRATION-EFFECT STUDIES WITH INTRAVENOUS METOCLOPRAMIDE

被引：92

作者：

BATEMAN, DN

KAHN, C

MASHITER, K

DAVIES, DS

机构：

[1] ROYAL POSTGRAD MED SCH,DEPT CLIN PHARMACOL,LONDON W12 0HS,ENGLAND

[2] ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND

来源：

关键词：

D O I：

10.1111/j.1365-2125.1978.tb04604.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：401 / 407

页数：7

共 22 条

[1] AHTEE L, 1975, BRIT J PHARMACOL, V55, P381, DOI 10.1111/j.1476-5381.1975.tb06941.x
[2] ABSORPTION AND ELIMINATION OF METOCLOPRAMIDE IN 3 ANIMAL SPECIES
BAKKE, OM
SEGURA, J
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (01) : 32 - 39
[3] BARBORIAK JJ, 1970, AM J CLIN NUTR, V23, P1151
[4] NON-INVASIVE TECHNIQUE FOR GASTRIC MOTILITY MEASUREMENT
BATEMAN, DN
LEEMAN, S
METREWELI, C
WILLSON, K
[J]. BRITISH JOURNAL OF RADIOLOGY, 1977, 50 (595) : 526 - 527
[5] IDENTIFICATION OF 4 NEW METABOLIC PRODUCTS OF METOCLOPRAMIDE USING MASS-SPECTROMETRY
COWAN, DA
HUIZING, G
BECKETT, AH
[J]. XENOBIOTICA, 1976, 6 (10) : 605 - 616
[6] DAVIES DS, 1977, CLIN PHARMACOL THER, V21, P593
[7] DONALDSON IM, 1976, BRIT J PHARMACOL, V56, pP373
[8] METOCLOPRAMIDE AS A DOPAMINE ANTAGONIST IN HEART AND GUT OF MOLLUSK TAPES-WATLINGI
DOUGAN, DFH
MEARRICK, PT
WADE, DN
[J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1974, 1 (06) : 473 - 478
[9] EISNER M, 1971, DIGESTIVE DISEASES, V16, P409
[10] ASSESSMENT OF GASTRIC-EMPTYING BY BREATHALYSER
FINCH, JE
KENDALL, MJ
MITCHARD, M
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (03) : 233 - 236